Our mission
Understanding Nature. Advancing Medicine.
Medicine has made remarkable progress. Yet we believe it's future will also be shaped by what science has yet to understand about nature and the human body.
From the endocannabinoid system to the broader therapeutic potential of naturally occurring compounds, we invest in the research, companies and pharmaceutical infrastructure that can translate scientific discoveries into evidence-based medicine.
Our approach
The value chain is our strategy.
We invest in and connect companies, capabilities and infrastructure across the pharmaceutical and healthcare ecosystem, creating long-term value from scientific discovery to patient access.
Invest
Strategic investments in pharmaceutical, phytopharmaceutical and healthcare companies, technologies and infrastructure.
Connect
Bringing together research, development, pharmaceutical operations and patient access through our companies and strategic partnerships.
Scale
Building long-term value through operational expertise, vertical integration and disciplined growth.
Portfolio
Our Investments
Building an integrated healthcare ecosystem through strategic investments and partnerships.
Pharmaceutical Infrastructure & Market Access · GermanyIntegrated pharmaceutical operations, packaging, quality and market access.
Pharmaceutical Compounding & Laboratory Services · SwitzerlandSpecialised pharmaceutical formulations and pharmacy-based laboratory services.
Pharmaceutical Care & Patient Access · ZurichPersonalised pharmaceutical care connecting modern medicine with individual patient needs.
Strategic Partnerships
Contact
Let’s talk.
We welcome conversations with investors, entrepreneurs and strategic partners.
Canna Capital Group AG
Bahnhofstrasse 3, CH-8808 Pfäffikon
contact@cannacapital.ch